Hill Country Authors – Exploring the Challenges of a Green Transition with Tom Ortiz
Daily Compliance News: August 5, 2025, The Staying Focused Edition
Daily Compliance News: August 1, 2025, The All AI Edition
Daily Compliance News: July 31, 2025 the Forgotten Generation Edition
Just Press "Play"
Everything Compliance: Shout Outs and Rants: Episode 158, No To Ukraine Corruption
Daily Compliance News: July 29, 2025 the Is CEO Conduct Ever Personal Edition
Daily Compliance News: July 25, 2025, The New Sheriff in Town Edition
Daily Compliance News: July 23, 2025 the Pardon in the Wind? Edition
Daily Compliance News: July 22, 2025, The I-9 Hell Edition
10 For 10: Top Compliance Stories For the Week Ending July 19, 2025
Sittenfeld v. United States – Campaign Contributions as Crimes?
Podcast - Walking Tall
Podcast - The Seeds of Corruption
The Dark Patterns Behind Corporate Scandals
10 For 10: Top Compliance Stories For the Week Ending June 21, 2025
Daily Compliance News: June 19, 2025, The Corruption in Spain Edition
Daily Compliance News: June 9, 2025, The Repugnant Edition
10 For 10: Top Compliance Stories For the Week Ending June 7, 2025
On January 14, 2025, China issued the final version of its compliance guidelines for health care companies to prevent commercial bribery risks (“Guidelines”), which took effect immediately. The Guidelines are applicable to...more
On January 10, 2025, China’s State Administration for Market Regulation (SAMR) officially released the Compliance Guidelines on Preventing Commercial Bribery Risks for Pharmaceutical Enterprises (the Guidelines). This...more
I continue with the multi-part blog post series based upon the New York Times (NYT) article by Alexandra Stevenson and Sui-Lee Wee, entitled “Selling CT Scanners with Bricks of Bills in China”, which details allegations of...more
After a sidetrack into the ethical train wreck detailed by the SEC Cease and Desist Order re: KPMG yesterday, I am returning to the blog post series I am running based upon the New York Times (NYT) reporting by Alexandra...more
In order to provide an overview for busy in-house counsel and compliance professionals, we summarize below some of the most important international anti-corruption developments from the past month, with links to primary...more
The SEC finished with the last nail in GSK China’s coffin by announcing a $20 FCPA million settlement for GSK’s violations in China. The Justice Department declined to prosecute this case. In 2014, a Chinese court...more
Last week a true American original died when Richard Trentlage passed away. If you do not know his name you certainly know signature contribution to American culture, the Oscar Meyer Weiner Song. Rather amazingly Trentlage...more
In an article, entitled “GSK China probe flags up wider worries”, in the Wednesday edition of the Financial Times (FT) reporters Andrew Jack and Patti Waldmeir discussed the ongoing bribery and corruption scandal involving...more
Ed. Note-this article is one of a continuing series of interviews of thought leaders in FCPA, Bribery Act and anti-corruption/anti-bribery. In this blog post, I interview Amy Sommers, partner in the Shanghai office of K&L...more
What is a sweep? It is certainly a well-known and relevant term in the sporting world....more
Mark Twain, one of my favorite authors, always said it best – “Do the right thing. It will gratify some people and astonish the rest.” - For drug and device companies, Mark Twain’s observation is becoming the industry...more